However, it is plausible that the heightened risk of neurodegeneration associated with ranibizumab may primarily affect individuals already predisposed to such side effects due to underlying factors like a family history of PD or AD, or the presence of uncompensated diabetes (Sultana and Scondotto 2020
Athletes under anti-doping jurisdiction, including USADA testing, should treat BPC-157 as prohibited and consult the current List
Li, L., Zeng, Q., Bhutkar, A., Galvan, J., Karamitopoulou, E., Necsulea, A., Noordermeer, D., Piersigilli, A., Peng, M., Perren, A., Ziobec, I., Robinson, H., Iruela-Arispe, M.L., and Hanahan, D., "GKAP acts as a genetic modulator of NMDAR signaling to govern invasive tumor growth", Cancer Cell 33 (4): 736-751 (2018)
The applicant explained that, after propensity score matching, Chew et al